Literature DB >> 30724005

Nonneutropenic fever in children with cancer: A scoping review of management and outcome.

Zoe Allaway1,2,3, Robert S Phillips4,5, Karin A Thursky2,3,6,7,8, Gabrielle M Haeusler1,2,3,6,7,8,9.   

Abstract

To date, very few studies have addressed nonneutropenic fever (NNF) in children with cancer, and there are no consensus guidelines. This scoping review aims to describe the rate of bacteremia, risk factors for infection and management, and outcomes of NNF in this population. Across 15 studies (n = 4106 episodes), the pooled-average bacteremia rate was 8.2%, and risk factors included tunneled external central venous catheter, clinical instability, and higher temperature. In two studies, antibiotics were successfully withheld in a subset of low-risk patients. Overall outcomes of NNF appear favorable; however, further research is required to determine its true clinical and economic impact.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  bacteremia; health services research; nonneutropenic fever; pediatric oncology

Mesh:

Substances:

Year:  2019        PMID: 30724005     DOI: 10.1002/pbc.27634

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

Review 1.  Diagnostic Stewardship in the Pediatric Intensive Care Unit.

Authors:  Anna C Sick-Samuels; Charlotte Woods-Hill
Journal:  Infect Dis Clin North Am       Date:  2022-03       Impact factor: 5.982

2.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

3.  Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.

Authors:  Adam J Esbenshade; Zhiguo Zhao; Alaina Baird; Emily A Holmes; Daniel E Dulek; Ritu Banerjee; Debra L Friedman
Journal:  J Clin Oncol       Date:  2020-08-07       Impact factor: 44.544

4.  Outcomes and Disposition of Oncology Patients With Non-neutropenic Fever and Positive Blood Cultures.

Authors:  Aditya Sharma; Jitsuda Sitthi-Amorn; Patrick Gavigan; Joshua Wolf; Asya Agulnik; Alex Brenner; Ying Li; Liza-Marie Johnson
Journal:  J Pediatr Hematol Oncol       Date:  2021-03-01       Impact factor: 1.170

5.  Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Authors:  Gabrielle M Haeusler; Karin A Thursky; Monica A Slavin; Franz E Babl; Richard De Abreu Lourenco; Zoe Allaway; Francoise Mechinaud; Robert Phillips
Journal:  EClinicalMedicine       Date:  2020-01-07

6.  Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.

Authors:  Jutarat Thangthong; Suvaporn Anugulruengkitt; Supanun Lauhasurayotin; Kanhatai Chiengthong; Hansamon Poparn; Darintr Sosothikul; Piti Techavichit
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

Review 7.  Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children.

Authors:  Jessica E Morgan; Bob Phillips; Gabrielle M Haeusler; Julia C Chisholm
Journal:  Infect Drug Resist       Date:  2021-03-30       Impact factor: 4.003

8. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.